KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $37.0 billion.

  • Gilead Sciences' Total Liabilities rose 237.44% to $37.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 billion, marking a year-over-year increase of 237.44%. This contributed to the annual value of $39.7 billion for FY2024, which is 73.39% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Total Liabilities is $37.0 billion, which was up 237.44% from $36.0 billion recorded in Q2 2025.
  • Gilead Sciences' 5-year Total Liabilities high stood at $48.5 billion for Q1 2021, and its period low was $35.4 billion during Q2 2024.
  • Moreover, its 5-year median value for Total Liabilities was $40.9 billion (2023), whereas its average is $41.1 billion.
  • Per our database at Business Quant, Gilead Sciences' Total Liabilities soared by 2919.44% in 2021 and then plummeted by 1421.09% in 2024.
  • Over the past 5 years, Gilead Sciences' Total Liabilities (Quarter) stood at $46.9 billion in 2021, then fell by 10.51% to $42.0 billion in 2022, then fell by 6.16% to $39.4 billion in 2023, then grew by 0.73% to $39.7 billion in 2024, then decreased by 6.74% to $37.0 billion in 2025.
  • Its last three reported values are $37.0 billion in Q3 2025, $36.0 billion for Q2 2025, and $37.3 billion during Q1 2025.